The FINANCIAL -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced the U.S. Food and Drug Administration has approved Jentadueto tablets, a new tablet combining the dipeptidyl peptidase-4 inhibitor, linagliptin, and metformin, according to Eli Lilly and Company.

The FINANCIAL -- Johnson & Johnson joined the World Health Organization, 12 other pharmaceutical companies, the Bill & Melinda Gates Foundation, the U.S. and U.K. governments, the World Bank , and officials from endemic countries in a new, coordinated action to eliminate or control by the end of the decade 10 neglected tropical diseases that affect more than a billion people in the world, from Johnson & Johnson. 

The FINANCIAL -- GlaxoSmithKline announced it has joined other global pharmaceutical companies and leading organisations including the World Health Organization, the Bill & Melinda Gates Foundation, the UK Department for International Development and the US Agency for International Development in a new united effort to support developing countries to defeat neglected tropical diseases.

The FINANCIAL -- Pfizer announced that the U.S. Food and Drug Administration has approved INLYTA, a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy, according to Pfizer.